- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Neoplasms, Castration-resistant in Finland
Total 244 results
-
Sven LöffelerOslo University Hospital; KlinbeforskRecruitingProstate CancerNorway, Denmark, Finland
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteCompletedCancer of the ProstateNetherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
-
Steba Biotech S.A.CompletedProstate CancerSpain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
-
Incyte CorporationTerminatedProstate CancerUnited States
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States, Guam
-
AgennixTerminatedProstate CancerUnited States
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
Antisoma ResearchCompletedProstate CancerUnited States
-
Helsinki University Central HospitalUniversity of Helsinki; HUSLABCompletedFluoroquinolone Resistant Enteric BacteriaFinland
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
GP-PharmCompletedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Tampere University HospitalTampere University; University of Eastern Finland; Finnish Cultural Foundation; Fimlab laboratoriesCompleted
-
Tampere University HospitalCompleted
-
Advaxis, Inc.Merck Sharp & Dohme LLCCompleted
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingProstate CancerUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Blue Earth DiagnosticsParexelCompletedProstate CancerUnited States, Finland, Netherlands
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
Ferring PharmaceuticalsTerminatedProstate CancerUnited States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom, Netherlands, Ireland, Greece, France, Belgium, Denmark, Norway, Italy, Slovakia, Switzerland, Portugal, Finland, Hungary, Germany
-
Active Biotech ABCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
DendreonCompletedProstate CancerUnited States, Canada
-
Brown UniversityTerminatedMelanoma | Prostate Cancer | Renal CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland